Clinical, biochemical and molecular investigations of three Taiwanese children with Laron syndrome

Journal of Pediatric Endocrinology and Metabolism

Volumn 17, Issue 2, 2004, Pages 165-171

  Yang, Chen ^a   Chen, Julia Yi Ru ^a,b   Lai, Chien Cherng ^a,b   Lin, Hsiu Chen ^a,b   Yeh, Geng Chang ^a,b   Hsu, Hsun Hui ^a,b  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Dwarfism; Growth hormone receptor; IGF I deficiency; Laron syndrome; Mutation

Indexed keywords

CHOLESTEROL; GROWTH HORMONE RECEPTOR; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; BIOCHEMISTRY; CASE REPORT; CHILD; CHILD CARE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONSANGUINEOUS MARRIAGE; CRANIOFACIAL MALFORMATION; EXON; FEMALE; FOREHEAD; HOMOZYGOSITY; HUMAN; LARON SYNDROME; MALE; MISSENSE MUTATION; OBESITY; PROTEIN BLOOD LEVEL; SEQUENCE ANALYSIS; SHORT STATURE; TAIWAN; VOICE;

EID: 3142698476     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2004.17.2.165     Document Type: Article

References (21)

1. Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentration of growth hormone: a new inborn error of metabolism? Isr J Med Sci 1966; 2: 152-155.
2. Laron Z, Pertzelan A, Karp M. Pituitary dwarfism with high serum levels of growth hormone. Isr J Med Sci 1968; 4: 883-894.
3. Laron Z, Klinger B. Laron syndrome: clinical features, molecular pathology and treatment. Horm Res 1994; 42: 198-202.
4. Godowski PJ, Leung DW, Meacham LR, Galgani JP, Hellmiss R, Keret R, Rotwein PS, Parks JS, Laron Z, Wood WI. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci USA 1989; 86: 8083-8087.
5. Wojcik J, Berg MA, Esposito N, Geffner ME, Sakati N, Reiter EO, Dower S, Francke U, Postel-Vinay MC, Finidori J. Four contiguous amino acid substitutions, identified in patients with Laron syndrome, differently affect the binding affinity and intracellular trafficking of the growth hormone receptor. J Clin Endocrinol Metab 1998; 83: 4481-4489.
6. Enberg B, Luthman H, Segnestam K, Ritzén EM, Sundstrom M, Norstedt G. Characterisation of novel missense mutations in the GH receptor gene causing severe growth retardation. Eur J Endocrinol 2000; 143: 71-76.
7. Laron Z, Klinger B, Eshet R, Kaneti H, Karasik A, Silbergeld A. Laron syndrome due to a post-receptor defect: response to IGF-I treatment. Isr J Med Sci 1993; 29: 757-763.
8. Laron Z, Pertzelan A, Karp M, Kowadlo-Silbergeld A, Daughaday WH. Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses. J Clin Endocrinol Metab 1971; 33: 332-342.
9. Savage MO, Burren CP, Blair JC, Woods KA, Metherell L, Clark AJ, Camacho-Hubner C. Growth hormone insensitivity: pathophysiology, diagnosis, clinical variation and future perspectives. Horm Res 2001; 55 (Suppl 2): 32-35.
10. Laron Z. Consequences of not treating children with Laron syndrome (primary growth hormone insensitivity). J Pediatr Endocrinol Metab 2001; 14 (Suppl 5): 1243-1248; discussion 1261-1262.
11. Eshet R, Laron Z, Pertzelan A, Arnon R, Dintzman M. Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism. Isr J Med Sci 1984; 20: 8-11.
12. Laron Z. Insulin-like growth factor 1 (IGF-I): a growth hormone. Mol Pathol 2001; 54: 311-316.
13. Laron Z, Blum W, Chatelain P, Ranke M, Rosenfeld R, Savage M, Underwood L. Classification of growth hormone insensitivity syndrome. J Pediatr 1993; 122: 241.
14. Ranke MB, Wollmann HA, Savage MO. Experience with insulin-like growth factor 1 (IGF-I) treatment of growth hormone insensitivity syndrome (GHIS). J Pediatr Endocrinol Metab 1999; 12 (Suppl 1): 259-266.
15. Baumann G. Growth hormone binding protein 2001. J Pediatr Endocrinol Metab 2001; 14: 355-375.
16. Kelly PA, Goujon L, Sotiropoulos A, Dinerstein H, Esposito N, Edery M, Finidori J, Postel-Vinay MC. The GH receptor and signal transduction. Horm Res 1994; 42: 133-139.
17. Woods KA, Clark AJ, Amselem S, Savage MO. Relationship between phenotype and genotype in growth hormone insensitivity syndrome. Acta Paediatr 1999; 88 (Suppl 428); 158-162; discussion 163.
18. Duquesnoy P, Sobrier ML, Duriez B, Dastot F, Buchanan CR, Savage MO, Preece MA, Craescu CT, Blouquit Y, Goossens M, et al. A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization. EMBO J 1994; 13: 1386-1395.
19. Rosenbloom AL, Martinez V, Kranzier JH, Bachrach LK, Rosenfeld RG, Guevara-Aguirre J. Natural history of growth hormone receptor deficiency. Acta Paediatr 1999; 88 (Suppl 428): 153-156; discussion 157.
20. Laron Z. Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome). J Pediatr Endocrinol Metab 1999; 12 (Suppl 1): 231-249.
21. Johnston LB, Savage MO. Partial growth hormone insensitivity. J Pediatr Endocrinol Metab 1999; 12 (Suppl 1): 251-257.